Abstracts

Cancer Stage at Diagnosis in HIV-Infected Individuals and Transplant Recipients

Background: Cancer risk is elevated with HIV infection; however, it is unknown whether immune suppression results in more aggressive, advanced stage cancers. As both tumor biology and delayed utilization of health care may lead to late stage of diagnosis among HIV-infected individuals, we compared cancer stage in HIV-infected individuals to solid organ transplant recipients, an…

Risk of Cancer Among HIV Patients Compared to the Background Population: Impact of Smoking and HIV

Background: The relative impact of immune deficiency and lifestyle related factors on risk of cancer in the HIV infected population is controversial. We aimed to estimate the population attributable fractions (PAFs) of cancer associated with smoking, immune deficiency and with being HIV-infected. Methodology: In a Danish, nationwide, population-based cohort study, 1995-2011, incidences of cancer were…

Risk Factors for Preterm Birth in Pregnant Women Randomized to Lopinavir- or Efavirenz-based ART

Background: Preterm birth (PTB) is a major cause of perinatal morbidity and mortality. HIV-infected pregnant women, particularly those with advanced disease, may have higher rates of PTB than HIV-uninfected women. As countries adopt WHO Option B+ and more women start combination antiretroviral therapy (cART), it is critical to understand risk factors for PTB among HIV-infected…

Comparative Genotoxic Signatures in Cord Blood Cells From Neonates Exposed to AZT or TDF In Utero

Background: Zidovudine (AZT) and tenofovir (TDF) are the most frequently used nucleoside analogues for reducing perinatal HIV transmission during pregnancy. Various genotoxicity biomarkers have been identified in neonates and animal models exposed to AZT in utero. In contrast, there are no data on TDF exposure – even though the compound is now considered by the…

Abnormal Fatty-Acid Oxidation in HIV-Exposed Uninfected Neonates in the United States

Background: Abnormal newborn screens for dysfunctional fatty acid oxidation (FAO) are more common in HIV-exposed uninfected (HEU) neonates than the general population and may be related to in utero exposure to HIV and/or combination antiretroviral therapy (cART). Normal FAO is necessary for normal growth and development. Disordered FAO can result in hypoglycemia, myopathy and liver…

In Utero Exposure to Zidovudine and Neonatal Heart Abnormalities in the ANRS-EPF/PRIMEVA Studies

Background: Antiretroviral therapy (ART) effectively prevents mother-to-child transmission of HIV. An increased risk of congenital heart defects (CHD) has been reported in infants exposed in utero to zidovudine, the association being strong and specific in a recent large EPF study. Observational studies have also found modification in myocardial mass and contractility in infants, particularly girls,…

Congenital Anomalies and in utero Antiretroviral Exposure in HIV-exposed Uninfected Children

Background: Most studies examining the association of maternal antiretroviral (ARV) exposures during pregnancy with congenital anomalies (CAs) in their children have been reassuring, but some suggest increased risk with specific ARVs. Methodology: We evaluated HIV-exposed uninfected children enrolled in the PHACS Surveillance Monitoring of ART Toxicities (SMARTT) study, an ongoing prospective cohort study initiated in…

Early Antiretroviral Therapy Appears to Normalize Intrathecal Markers of Immune Activation

Background: Central nervous system (CNS) viral invasion and accompanying neuroinflammation occur early after systemic HIV infection, and are a substrate for neurological injury in untreated disease. Markers of inflammation in the CNS have been shown to remain elevated in the presence of antiretroviral therapy (ART) initiated during chronic infection, yet the extent to which elevations…

Immediate Antiretroviral Therapy Mitigates the Development of Neuronal Injury in Acute HIV

Background: Neurofilament light chain (NFL) in cerebrospinal fluid (CSF) is a sensitive marker of axonal injury that is elevated in neurodegenerative disorders, HIV-associated dementia, and some neuroasymptomatic subjects during the early and late stages of HIV infection. We sought to determine whether axonal injury can be detected acutely after HIV transmission, and if initiation of…